People
Clario acquires imaging provider NeuroRx
18 March 2025 - Clario, a US provider of endpoint data solutions to the clinical trial industry, announced on Monday that it has acquired NeuroRx, a Canada-based provider of imaging analysis with expe...
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
17 March 2025 - Medical technology company Healthcare Holding Schweiz AG announced on Monday that it has completed the acquisition of Effectum CH-Rep AG, effectively carving out all Swiss Authorized R...
iOncologi acquires TargImmune Therapeutics
17 March 2025 - iOncologi Inc, a US-based clinical-stage biopharmaceutical company, announced on Friday that it has acquired TargImmune Therapeutics, a Swiss biotechnology company specialising in nove...
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
11 March 2025 - Indian pharmaceutical company Zydus Lifesciences Limited (NSE:ZYDUSLIFE) has entered exclusive negotiations to acquire 85.6% of French surgical technology company Amplitude Surgical (E...
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
27 February 2025 - Danish biotech company Adcendo announced on Wednesday that it has received approval from the US Food & Drug Administration (FDA) for its IND application for a Phase I study asse...
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
6 February 2025 - Australian biotechnology company Actinogen Medical Limited (ASX:ACW) announced on Wednesday that the World Health Organisation (WHO) has granted the non-proprietary name of 'eme...